Year: 2008
Type: article
Abstract: Grazax is a novel sublingual formulation of grass pollen allergen for the treatment of hay fever in adults. In our Drugs in focus review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Professor Stephen Durham comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd
Source: Prescriber
DOI: 10.1002/psb.269
Authors: Steve Chaplin, Stephen Durham
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,500
OpenAlex ID: W2036716994